The World Congress Summit on Real World Data Strategies 2014 covers topics such as:
- Develop Better Treatment Pathways and Optimize Efficacy in Comparative Effectiveness Research
- The Future of Regulations—Understand the Sentinel Initiative and the Next Steps for the FDA
- Create Interoperability Between Electronic Data Sources to Enhance Data for Demonstrating Improved Outcomes
- Maximize Value of Registry Data for Improved Discovery and Innovation
- The Intersection of Pharmaceutical Manufacturers and ACOs—Leveraging Data for New Payment Models
- Balancing Data Expectations of Regulators and Payers for an Efficient Post-Marketing Strategy
- Enhance Large Scale Clinical Data Association Studies with Privacy Protections
- Data Linkages: How Real World Data can be Maximized to Support Development and Post Marketing Research Programs
- Case Study: Patients Like Me—The Evolution of a Patient Powered Research Network
- Prepare for the Future of Big Data – How to Create Richer Data Sources Now
- Case Study: Disease Registries—Real World Study Design
The World Congress Summit on Real World Data Strategies 2014 brings together biotech and pharmaceutical VPs, SVPs and Directors of:
- Post-Approval/Post-Marketing
- Phase IV/Late Phase
- Outcomes Research
- Health Economics
- Patient Registries
- Real World Data/Evidence
- Medical Affairs
- Disease Registries
- Clinical Operations
- Clinical Affairs
- Surveillance/Safety
- Scientific Affairs
- Pharmacovigilance
- Regulatory Affairs
- Risk Management